Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index; 15 of the 21 sources its claims cite were checked for support.

The Synergistic Effect of Proanthocyanidin and HDAC Inhibitor Inhibit Breast Cancer Cell Growth and Promote Apoptosis

Open access
Wang, Tsz Ki, Xu, Shaoting, Fan, Yuanjian, Wu, Jing, Wang, Zilin, Chen, Yue, Zhang, Yunjian·2023·International Journal of Molecular Sciences

Abstract

Histone deacetylase inhibitor (HDACi) is a drug mainly used to treat hematological tumors and breast cancer, but its inhibitory effect on breast cancer falls short of expectations. Grape seed proanthocyanidin extract (GSPE) with abundant proanthocyanidins (PAs) has been explored for its inhibition of HDAC activity in vitro and in vivo. To enhance HDACi's effectiveness, we investigated the potential of PA to synergistically enhance HDACi chidamide (Chi), and determined the underlying mechanism. We evaluated the half-inhibitory concentration (IC50) of PA and Chi using the cell counting kit 8 (CCK8), and analyzed drugs' synergistic effect with fixed-ratio combination using the software Compusyn. Breast cancer cell's phenotypes, including short-term and long-term proliferation, migration, invasion, apoptosis, and reactive oxygen species (ROS) levels, were assessed via CCK8, clone-formation assay, wound-healing test, Transwell Matrigel invasion assay, and flow-cytometry. Protein-protein interaction analysis (PPI) and KEGG pathway analysis were used to determine the underlying mechanism of synergy. PA + Chi synergistically inhibited cell growth in T47D and MDA-MB-231 breast cancer cell lines. Short-term and long-term proliferation were significantly inhibited, while cell apoptosis was promoted. Ten signaling pathways were identified to account for the synergistic effect after RNA sequencing. Their synergism may be closely related to the steroid biosynthesis and extracellular matrix (ECM) receptor interaction pathways. PA + Chi can synergistically inhibit breast cancer cell growth and proliferation, and promote apoptosis. These effects may be related to steroid biosynthesis or the ECM receptor pathway.

Overview

CoChat Summary

TL;DR

Proanthocyanidin (PA) combined with the HDAC inhibitor chidamide (Chi) synergistically inhibited breast cancer cell growth and proliferation and promoted apoptosis in T47D and MDA-MB-231 cells. The synergy was associated with steroid biosynthesis and ECM receptor interaction pathways.

Key findings

  • PA + Chi showed synergistic growth inhibition in T47D at an 18.5:1 ratio and in MDA-MB-231 at a 50:1 ratio; IC50 values were PA 90.74 µg/mL and Chi 9.778 µM in T47D, and PA 87.9 µg/mL and Chi 3.096 µM in MDA-MB-231.
  • Clone formation was significantly reduced by PA + Chi (133 ± 40 colonies) versus control (467 ± 92), PA (386 ± 100), and Chi (806 ± 131) (all p < 0.05).
  • Apoptosis was increased by PA + Chi: 14.9% early and 31.8% late apoptosis, versus control 6.39% early and 12.0% late, PA 4.68% early and 10.9% late, and Chi 4.3% early and 20.8% late.
  • RNA sequencing identified 247 potentially synergistic DEGs after excluding 187 shared PA/Chi genes; KEGG analysis found 21 pathways with nominal p < 0.05, and PPI highlighted steroid biosynthesis and ECM receptor interaction as most promising.

Methods

  • T47D and MDA-MB-231 breast cancer cell lines were used; ER+ cell line selection was based on HDAC1/2/3/10 expression from GEO single-cell RNA-seq dataset GSE173634.
  • Drug effects were assessed by CCK8 IC50, Compusyn fixed-ratio synergy analysis, short-term proliferation, clone formation, wound healing, Transwell Matrigel invasion, Annexin V-FITC/PI apoptosis flow cytometry, and DHE ROS flow cytometry.
  • Transcriptome sequencing used 12 T47D samples across four groups with three replicates; DEGs were called at FDR < 0.05 and FC ± 2, followed by KEGG pathway annotation and STRING PPI analysis; statistics used one-way ANOVA with p < 0.05.

Limitations

  • The paper states that the entire pathway and specific genes involved in the synergistic effect were not confirmed, and that post-transcriptional regulation by HDACi was not addressed; shRNA interference and in vivo experiments are warranted.
  • Evident from the text: all reported experiments are in vitro, using T47D and MDA-MB-231 cells, with no in vivo validation reported.
  • Evident from the text: the mechanistic conclusion relies on transcriptome sequencing and bioinformatic enrichment/PPI rather than direct functional validation of steroid biosynthesis or ECM receptor pathways.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms241310476

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 (a) Violin plot depicting the expression levels of HDACs in commonly used estrogen-positive breast cancer cell lines (BT474, MCF7, T47D, and ZR751). (For gene expression level, n = 2158 (BT474), n = 839 (MCF7), n = 825 (T47D), and n = 943 (ZR751). ns p > 0.05, * p < 0.05, ** p < 0.01, or **** p < 0.0001, statistical significances were assessed by one-way ANOVA after the D’Agostino-Pearson normality test). (b) Cell inhibition curve and logarithmic combination index (LogCI) value after treating T47D cells with a proanthocyanidin and chidamide (PA + Chi) ratio of 18.5 to 1. LogCI value < 0 indicates synergistic effect between drugs. (c) Cell inhibition curve and LogCI value after treating MDA-MB-231 cells with a PA + Chi ratio of 50 to 1.
Figure 1 (a) Violin plot depicting the expression levels of HDACs in commonly used estrogen-positive breast cancer cell lines (BT474, MCF7, T47D, and ZR751). (For gene expression level, n = 2158 (BT474), n = 839 (MCF7), n = 825 (T47D), and n = 943 (ZR751). ns p > 0.05, * p < 0.05, ** p < 0.01, or **** p < 0.0001, statistical significances were assessed by one-way ANOVA after the D’Agostino-Pearson normality test). (b) Cell inhibition curve and logarithmic combination index (LogCI) value after treating T47D cells with a proanthocyanidin and chidamide (PA + Chi) ratio of 18.5 to 1. LogCI value < 0 indicates synergistic effect between drugs. (c) Cell inhibition curve and LogCI value after treating MDA-MB-231 cells with a PA + Chi ratio of 50 to 1.CC BY · PubMed Central
Figure 2 (a) Proliferation curves of T47D cells treated with proanthocyanidins (PA), chidamide (Chi), and their combination (PA + Chi), and the difference at day 7 after treatment. (For proliferation rate (%), n = 9 (Control), n = 9 (PA), n = 9 (Chi), and n = 9 (PA + Chi). * p < 0.05, or **** p < 0.0001). (b) Clone formation assay showing the number of cell colonies formed by T47D cells treated with PA, Chi, PA + Chi, and the control group. (For clone number present in histogram, n = 3 (Control), n = 3 (PA), n = 3 (Chi), and n = 3 (PA + Chi). * p < 0.05, or *** p < 0.001). (c) Wound-healing assay results comparing T47D cell migration from 0 h to 72 h after treatment with PA, Chi, and PA + Chi. (×40) (d) Transwell assay evaluating the invasive ability of T47D cells treated with PA, Chi, PA + Chi, and the control group. Representative photographs and quantification of migrated cells through the upper chamber are shown. The number of cells adhering to the outside membrane after 48 h was counted in five randomly selected views (×200; For migration cell number, n = 5 (Control), n = 5 (PA), n = 5 (Chi), and n = 5 (PA + Chi). * p < 0.05). (e) Apoptosis levels of T47D cells treated with PA, Chi, or PA + Chi compared to the control group. Upper left: control; upper right: PA; bottom left: Chi; bottom right: PA + Chi. (f) Percentage increase in reactive oxygen species (ROS) in T47D cells treated with PA, Chi, and PA + Chi. No synergistic effect on ROS percentage change was observed. Statistical analysis for all quantitative multi-group comparisons in the histograms was performed using one-way ANOVA (Brown-Forsythe and Welch ANOVA tests for data with non-equal standard deviations).
Figure 2 (a) Proliferation curves of T47D cells treated with proanthocyanidins (PA), chidamide (Chi), and their combination (PA + Chi), and the difference at day 7 after treatment. (For proliferation rate (%), n = 9 (Control), n = 9 (PA), n = 9 (Chi), and n = 9 (PA + Chi). * p < 0.05, or **** p < 0.0001). (b) Clone formation assay showing the number of cell colonies formed by T47D cells treated with PA, Chi, PA + Chi, and the control group. (For clone number present in histogram, n = 3 (Control), n = 3 (PA), n = 3 (Chi), and n = 3 (PA + Chi). * p < 0.05, or *** p < 0.001). (c) Wound-healing assay results comparing T47D cell migration from 0 h to 72 h after treatment with PA, Chi, and PA + Chi. (×40) (d) Transwell assay evaluating the invasive ability of T47D cells treated with PA, Chi, PA + Chi, and the control group. Representative photographs and quantification of migrated cells through the upper chamber are shown. The number of cells adhering to the outside membrane after 48 h was counted in five randomly selected views (×200; For migration cell number, n = 5 (Control), n = 5 (PA), n = 5 (Chi), and n = 5 (PA + Chi). * p < 0.05). (e) Apoptosis levels of T47D cells treated with PA, Chi, or PA + Chi compared to the control group. Upper left: control; upper right: PA; bottom left: Chi; bottom right: PA + Chi. (f) Percentage increase in reactive oxygen species (ROS) in T47D cells treated with PA, Chi, and PA + Chi. No synergistic effect on ROS percentage change was observed. Statistical analysis for all quantitative multi-group comparisons in the histograms was performed using one-way ANOVA (Brown-Forsythe and Welch ANOVA tests for data with non-equal standard deviations).CC BY · PubMed Central
Figure 3 (a) Venn diagram illustrating the overlap of differentially expressed gene (DEG) in T47D cells treated with drugs. (b) Significantly associated pathways, up-regulated or down-regulated, possibly involved in the synergistic effect of proanthocyanidin (PA) and chidamide (Chi) on breast cancer cell characteristics or functions. (c) Protein–protein interaction (PPI) analysis of 48 DEGs related to T47D cells’ characteristics or functions using the STRING online tool.
Figure 3 (a) Venn diagram illustrating the overlap of differentially expressed gene (DEG) in T47D cells treated with drugs. (b) Significantly associated pathways, up-regulated or down-regulated, possibly involved in the synergistic effect of proanthocyanidin (PA) and chidamide (Chi) on breast cancer cell characteristics or functions. (c) Protein–protein interaction (PPI) analysis of 48 DEGs related to T47D cells’ characteristics or functions using the STRING online tool.CC BY · PubMed Central

Verification

Claims the paper makes

7 Valid · 1 Not valid · 1 Not checked · 40 Own results and interpretations

30 more claims

Create a free account to see all 49 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 11
  • Probably not a substantial claim. 4

Create a free account to see these claims.

Citations

Cites

Show all 35 references

Cited by

See all 18

Metadata

Authors
Wang, T. K., Xu, S., Fan, Y., Wu, J., Wang, Z., Chen, Y., & Zhang, Y.
Affiliations
The First Affiliated Hospital, Sun Yat-sen University (CN)
Corresponding author
Zhang, Yunjian
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2023-06-22
Volume
24
Issue
13
Pages
10476
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4381617893
Cited by
18
References
35
Citations by year
2026: 4 · 2025: 10 · 2024: 3 · 2023: 1
FWCI
1.60
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81872344)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
Keywords
proanthocyanidins, grape seed proanthocyanidin extract, histone deacetylase inhibitors, chidamide, synergistic drug combination, breast cancer, apoptosis, cell proliferation, cell migration and invasion, reactive oxygen species, steroidogenesis, T47D cells, MDA-MB-231 cells
MeSH terms
Neoplasms, Steroids, Apoptosis, Proanthocyanidins, Cell Line, Tumor, Cell Proliferation, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Synergistic Effect of Proanthocyanidin and HDAC Inhibitor Inhibit Breast Cancer Cell Growth and Promote Apoptosis. https://app.cochat.ai/papers/10.3390/ijms241310476
The paper
Wang, T. K., Xu, S., Fan, Y., Wu, J., Wang, Z., Chen, Y., & Zhang, Y. (2023). The Synergistic Effect of Proanthocyanidin and HDAC Inhibitor Inhibit Breast Cancer Cell Growth and Promote Apoptosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310476

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.